Anemia Research Today is a free monthly online journal that collates and summarizes the latest research about Anemia, including details on symptoms, diagnosis, diet, treatment, causes.

Volume 4 (2007), Issue 3 (March)

1. Marked hyperbilirubinemia associated with the heme oxygenase-1 gene promoter microsatellite polymorphism in a boy with autoimmune hemolytic anemia.
   Pediatrics, 119(3): e764-7. [Abstract] [Full-text]
2. Orbital wall infarction mimicking periorbital cellulitis in a patient with sickle cell disease.
   Pediatr Radiol, 37(4): 388-90. [Abstract] [Full-text]
3. The effect of deoxygenation on whole-cell conductance of red blood cells from healthy individuals and patients with sickle cell disease.
   Blood, 109(6): 2622-9. [Abstract] [Full-text]
4. Involvement of the fractalkine pathway in the pathogenesis of childhood hemolytic uremic syndrome.
   Blood, 109(6): 2438-45. [Abstract] [Full-text]
5. Specific antibodies to moesin, a membrane-cytoskeleton linker protein, are frequently detected in patients with acquired aplastic anemia.
   Blood, 109(6): 2514-20. [Abstract] [Full-text]
6. When to start supplementary iron to prevent iron deficiency in early childhood in sub-Saharan Africa setting.
   Pediatr Blood Cancer, 48(5): 544-9. [Abstract] [Full-text]
7. Survival, mortality, and complications in patients with beta-thalassemia major in northern Taiwan.
   Pediatr Blood Cancer, 48(5): 550-4. [Abstract] [Full-text]
8. Treatment for children with severe aplastic anemia and sickle cell disease in low income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO): Part III.
   Pediatr Blood Cancer, 48(5): 598-9. [Abstract] [Full-text]
9. Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia.
   J Clin Oncol, 25(9): 1027-32. [Abstract] [Full-text]
10. Immune-mediated hepatitis-associated aplastic anemia caused by the emergence of a mutant hepatitis B virus undetectable by standard assays.
    J Hepatol, 46(4): 743-7. [Abstract] [Full-text]
11. Endothelial function and arterial stiffness in sickle-thalassemia patients.
    Atherosclerosis, 191(2): 427-32. [Abstract] [Full-text]
12. Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia.
    Atherosclerosis, 191(2): 397-402. [Abstract] [Full-text]
13. Australian haemodialysis patients on intravenous epoetin alfa or intravenous darbepoetin alfa: how do they compare?
    Nephrology (Carlton), 12(2): 126-9. [Abstract] [Full-text]
14. Dose of epoetin alfa used in haemodialysis patients when switching from subcutaneous to intravenous administration.
    Nephrology (Carlton), 12(2): 120-5. [Abstract] [Full-text]
15. MRI for the determination of pituitary iron overload in children and young adults with beta-thalassaemia major.
    Eur J Radiol, 62(1): 138-42. [Abstract] [Full-text]
16. Hypochromic erythrocytes (%): a reliable marker for recognizing iron-restricted erythropoiesis and predicting response to erythropoietin in anemic patients with myeloma and lymphoma.
    Ann Hematol, 86(5): 369-76. [Abstract] [Full-text]
17. Zinc protoporphyrin, a useful parameter to address hyperferritinemia.
    Ann Hematol, 86(5): 363-8. [Abstract] [Full-text]
18. Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases.
    Bone Marrow Transplant, 39(7): 383-8. [Abstract] [Full-text]
19. Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload.
    Am J Hematol, 82(4): 255-65. [Abstract] [Full-text]
20. Adherent leukocytes capture sickle erythrocytes in an in vitro flow model of vaso-occlusion.
    Am J Hematol, 82(4): 266-75. [Abstract] [Full-text]
21. Management of cancer-associated thrombotic microangiopathy: what is the right approach?
    Am J Hematol, 82(4): 295-8. [Abstract] [Full-text]
22. PTPN22 620W allele is not associated with aplastic anemia.
    Am J Hematol, 82(4): 291-2. [Abstract] [Full-text]
23. Bone marrow aplasia--a rare complication of imatinib therapy in CML patients.
    Am J Hematol, 82(4): 314-6. [Abstract] [Full-text]
24. Therapeutic use of erythropoietin in dermatooncology.
    J Dtsch Dermatol Ges, 5(4): 280-5. [Abstract] [Full-text]
25. Nonimmune hydrops fetalis in two cases of consanguineous parents and associated with hereditary spherocytosis and hemophagocytic hystiocytosis.
    J Perinatol, 27(4): 252-4. [Abstract] [Full-text]
26. Micronutrient supplements for children after deworming.
    Lancet Infect Dis, 7(4): 297-302. [Abstract] [Full-text]
27. The role of Wilms' tumor gene peptide-specific cytotoxic T lymphocytes in immunologic selection of a paroxysmal nocturnal hemoglobinuria clone.
    Exp Hematol, 35(4): 618-26. [Abstract] [Full-text]
28. The pathophysiology of paroxysmal nocturnal hemoglobinuria.
    Exp Hematol, 35(4): 523-33. [Abstract] [Full-text]
29. Erythropoietin and iron-restricted erythropoiesis.
    Exp Hematol, 35(4): 167-72. [Abstract] [Full-text]
30. Continuing anemia prevention strategies are needed throughout early childhood in low-income preschool children.
    J Pediatr, 150(4): 422-8, 428.e1-2. [Abstract] [Full-text]
31. Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment.
    Biol Blood Marrow Transplant, 13(4): 469-77. [Abstract] [Full-text]
32. Lymphangiosarcoma in two cats.
    J Feline Med Surg, 9(2): 161-7. [Abstract] [Full-text]
33. Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity.
    Nephrol Dial Transplant, 22(4): 1156-62. [Abstract] [Full-text]
34. Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy.
    Gynecol Oncol, 105(1): 199-204. [Abstract] [Full-text]
35. Clinical expression of co-inherited Dubin-Johnson and thalassaemic heterozygous states.
    Dig Liver Dis, 39(4): 369-74. [Abstract] [Full-text]
36. Hemoglobin variation and blood transfusion rates in patients affected by locally advanced cervical cancer undergoing neo-adjuvant chemotherapy followed by radical surgery: the role of erythropoietic growth factors.
    Ann Oncol, 18(4): 722-9. [Abstract] [Full-text]
37. Anaemia-related impairment in quality of life in elderly cancer patients prior to chemotherapy.
    J Cancer Res Clin Oncol, 133(5): 279-86. [Abstract] [Full-text]
38. Management of a young patient with combined autoimmunity: Evans syndrome: a case report.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 103(4): 505-11. [Abstract] [Full-text]
39. Noninvasive liver-iron measurements with a room-temperature susceptometer.
    Physiol Meas, 28(4): 349-61. [Abstract] [Full-text]
40. Can haematological indices predict positive findings at endoscopy in anaemic patients?
    Ann R Coll Surg Engl, 89(3): 221-5. [Abstract] [Full-text]
41. Molecular analysis of alpha/beta-thalassemia in a southern Chinese population.
    Genet Test, 11(1): 75-83. [Abstract] [Full-text]
42. Chk1-mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathway.
    Mol Cell Biol, 27(8): 3098-108. [Abstract] [Full-text]

© 2004-2008 Anemia Research Today. All Rights Reserved.